Search research articles
Contact Us
Filters
Showing results (51-60 of 164) with videos related to
Page
of 17
Sort By:
Diabetes Research and Clinical Practice
|
June 16, 2005
What do we (not) know about apoB, type 2 diabetes and obesity?
J Smith, M Al Amri, Allan D Sniderman
JAMA Cardiology
|
August 10, 2017
The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines
George Thanassoulis, Michael J Pencina, Allan D Sniderman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 4, 2023
Maud Ahmad, Allan D Sniderman, Robert A Hegele
Journal of the American College of Cardiology
|
June 5, 2024
ApoB Is Ready for Prime Time
Alan T Remaley, Justine Cole, Allan D Sniderman
Current Opinion in Lipidology
|
September 29, 2023
Triglyceride-rich lipoprotein cholesterol and cardiovascular risk
Selin Bilgic, Alan T Remaley, Allan D Sniderman
JAMA Cardiology
|
November 13, 2021
Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk: The Debate Is Over
Allan D Sniderman, Ann Marie Navar, George Thanassoulis
JAMA Cardiology
|
July 21, 2016
The Enigma of Glucose and Lipid Metabolism
Neha J Pagidipati, Michael Pencina, Allan D Sniderman
Current Opinion in Cardiology
|
May 11, 2012
Low-density lipoprotein-lowering strategies: target versus maximalist versus population percentile
Allan D Sniderman, Jacqueline De Graaf, Patrick Couture
European Heart Journal
|
August 12, 2025
Myocardial compression and recoil as determinants of coronary blood flow
Allan D Sniderman, Kevin J Lachapelle, George Thanassoulis
JAMA Cardiology
|
July 21, 2016
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events
Allan D Sniderman, George Thanassoulis, Ken Williams, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 164) with videos related to
Sort By:
Page
of 17
Diabetes Research and Clinical Practice
|
June 16, 2005
What do we (not) know about apoB, type 2 diabetes and obesity?
J Smith, M Al Amri, Allan D Sniderman
JAMA Cardiology
|
August 10, 2017
The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines
George Thanassoulis, Michael J Pencina, Allan D Sniderman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
December 4, 2023
Maud Ahmad, Allan D Sniderman, Robert A Hegele
Journal of the American College of Cardiology
|
June 5, 2024
ApoB Is Ready for Prime Time
Alan T Remaley, Justine Cole, Allan D Sniderman
Current Opinion in Lipidology
|
September 29, 2023
Triglyceride-rich lipoprotein cholesterol and cardiovascular risk
Selin Bilgic, Alan T Remaley, Allan D Sniderman
JAMA Cardiology
|
November 13, 2021
Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk: The Debate Is Over
Allan D Sniderman, Ann Marie Navar, George Thanassoulis
JAMA Cardiology
|
July 21, 2016
The Enigma of Glucose and Lipid Metabolism
Neha J Pagidipati, Michael Pencina, Allan D Sniderman
Current Opinion in Cardiology
|
May 11, 2012
Low-density lipoprotein-lowering strategies: target versus maximalist versus population percentile
Allan D Sniderman, Jacqueline De Graaf, Patrick Couture
European Heart Journal
|
August 12, 2025
Myocardial compression and recoil as determinants of coronary blood flow
Allan D Sniderman, Kevin J Lachapelle, George Thanassoulis
JAMA Cardiology
|
July 21, 2016
Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular Events
Allan D Sniderman, George Thanassoulis, Ken Williams, et al.
Page
of 17